Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 495 clinical trials
None

  • None views
None

  • None views
None

  • None views
Neurodegenerative Diseases Registry

Due to the overlapping presentation and similar brain pathology, especially in the early stage of the diseases, it is difficult to differentiate idiopathic Parkinson's disease (iPD) from atypical parkinsonian syndromes, such as multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Similarly, distinguishing AD from other dementia syndromes including frontotemporal …

progressive supranuclear palsy
multiple system atrophy
parkinson's disease
atrophy
lewy body disease
  • 0 views
  • 19 Feb, 2024
TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

TRACK-MSA is an observational, non-interventional, longitudinal natural history study to define changes in clinical, neurological, blood, CSF, and neuroimaging biomarkers in patients with multiple system atrophy (MSA) comparing baseline to 6-month and 1-year assessments. The study will enroll 50 patients with MSA-P or MSA-C at 2 or more participating sites.

atrophy
mri brain
brain mri
  • 0 views
  • 19 Feb, 2024